Copyright
©The Author(s) 2023.
World J Hepatol. Oct 27, 2023; 15(10): 1091-1108
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1091
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1091
Table 1 Flavonoids improve hepatic fibrosis by inhibiting oxidative stress
No. | Flavonoids | Model | Upregulated molecules | Downregulated molecules | Mechanism | Ref. |
1 | Mallotus apelta (Lour.) Muell.Arg. leaf | Rat | IkBa, SOD, GSH-Px | HYP, PC-III, Col-I, HA, LN, α-SMA, Col-III, MDA, TNF-α, IL-1β, IL-6, MMP-2/9, TIMP-1, TGF-β1/Smad, IKKβ, NF-κB p65, pNF-κBp65, IκBα, p-IκBα | Improving hepatic fibrosis and reducing ECM accumulation are related to inhibiting OS and regulating the TGF-β1/Smad signaling pathway and NF-κB-dependent inflammatory response | Zhang et al[117] |
2 | Bidens bipinnata L. | Rat | SOD, GSH-Px | NF-κB, α-SMA, TGF-β1 | Inhibiting OS to improve liver injury and protect rats from CCl4-induced hepatic fibrosis | Yuan et al[118] |
3 | Puerarin | Rat | SOD, CAT | TG, TCHO, LDL, α-SMA, Col-I/III, MDA, IL-1β, IL-6, TNF-α, MCP-1, NF-κB/p65, TGF-β, TGF-β/Smad2/3 | Inhibiting OS and inflammation associated with NF-κB signal inactivation, thereby blocking the upregulation of pro-inflammatory cytokines (IL-1β and TNF-α) and chemokines (MCP-1), ultimately improving hepatic fibrosis | Hou et al[119] |
4 | Hesperidin | Mice | ROS | Regulating liver OS and alleviating mitochondrial dysfunction to reduce fibrosis | Li et al[120] | |
5 | Alpinetin | Mice | IL-10, CAT, GSH-Px, SOD, GSH, Nrf2 | HYP, α-SMA, fibronectin, α1(I) procollagen, IL-1β, IL-6, TNF-α, Cox-2, iNOS, MDA, VEGF, VEGFR2, PDGF-βR, HIF-1α | Preventing and treating hepatic fibrosis by inhibiting the anti-inflammatory activity mediated by NLRP3 and the anti-OS activity mediated by Nrf2 | Zhu et al[121] |
6 | Fisetin | Rat | GSH, GSK-3β | MDA, TNF-α, IL-6, TGF-β1, Col-I, TIMP-1, Wnt3a, β-catenin, α-SMA, Cyclin D1 | Inhibiting liver OS can suppress Wnt/β-catenin pathway and inhibit HSC activation and proliferation, regulate MMP-9 and TIMP-1, and suppress multiple pro-fibrotic factors, to prevent and treat hepatic fibrosis | El-Fadaly et al[122] |
7 | Glabridin | Mice | PPAR-γ, GSH, T-AOC | α-SMA, fibronectin, Col-α1(I), MDA | Activation of PPARγ can inhibit inflammation and OS, thereby inhibiting HSC activation and hepatic fibrosis | Zhang et al[123] |
8 | Morin | Rat | GSH | NO, HYP, TNF-α, iNOS, NF-κB (p65) | Receiving MDA and nitric oxide levels elevation, and restoring GSH to normal levels can inhibit OS and improve hepatic fibrosis | Heeba and Mahmoud[124] |
9 | Astilbin | Rat | SOD, GSH, GCLC, GCLM, HO-1, NQO1, Nrf2 | TGF-β, Col-I/III, HYP, TNF-α, IL-1β, IL-6, MDA | Significant reduction in collagen production, inflammation and OS in vivo can prevent CCL4-induced hepatic fibrosis in rats | Sun et al[125] |
- Citation: Li Z, Zhu JF, Ouyang H. Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress. World J Hepatol 2023; 15(10): 1091-1108
- URL: https://www.wjgnet.com/1948-5182/full/v15/i10/1091.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i10.1091